Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Tipo de estudo
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Appl Radiat Isot ; 172: 109651, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33740668

RESUMO

Nondestructive microbeam X-ray fluorescence (µXRF) spectrometry has been used to investigate the elemental microheterogeneity in a nuclear forensics reference material (RM), NIST SRM 4600 Surrogate Post-detonation Urban Debris. Using a principal component analysis (PCA) model, results indicate the majority of elements appear homogeneous; however, zinc (Zn) exhibits microscale heterogeneity for this SRM. To minimize contributions to the measurement uncertainty from elemental microheterogeneity, a minimum sample mass of 24 mg is recommended for analysis.

2.
Genetics ; 192(2): 385-96, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22851646

RESUMO

Identifying genomic alterations driving breast cancer is complicated by tumor diversity and genetic heterogeneity. Relevant mouse models are powerful for untangling this problem because such heterogeneity can be controlled. Inbred Chaos3 mice exhibit high levels of genomic instability leading to mammary tumors that have tumor gene expression profiles closely resembling mature human mammary luminal cell signatures. We genomically characterized mammary adenocarcinomas from these mice to identify cancer-causing genomic events that overlap common alterations in human breast cancer. Chaos3 tumors underwent recurrent copy number alterations (CNAs), particularly deletion of the RAS inhibitor Neurofibromin 1 (Nf1) in nearly all cases. These overlap with human CNAs including NF1, which is deleted or mutated in 27.7% of all breast carcinomas. Chaos3 mammary tumor cells exhibit RAS hyperactivation and increased sensitivity to RAS pathway inhibitors. These results indicate that spontaneous NF1 loss can drive breast cancer. This should be informative for treatment of the significant fraction of patients whose tumors bear NF1 mutations.


Assuntos
Neoplasias da Mama/genética , Neoplasias Mamárias Animais/genética , Neurofibromina 1 , Proteínas ras , Animais , Neoplasias da Mama/etiologia , Células Cultivadas , Hibridização Genômica Comparativa , Variações do Número de Cópias de DNA/genética , Feminino , Regulação Neoplásica da Expressão Gênica , Instabilidade Genômica , Humanos , Neoplasias Mamárias Animais/etiologia , Camundongos , Neurofibromina 1/genética , Neurofibromina 1/metabolismo , Proteínas ras/genética , Proteínas ras/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA